PDL BioPharma, Inc.

Q3 2017 13F Holders

Symbol
PDLI
CUSIP
69329Y104
Type
Equity
Class
COM
Num filers
187
Total reported value, excl. options
$467M
Manager Report Date Value ($000) Shares Option Type